HGF/c-Met Signalling in the Tumor Microenvironment.
Alberto Zambelli1, Giuseppe Biamonti2, Angela Amato3
1Unit of Oncology, Ospedale Papa Giovanni XXIII, Bergamo, Italy.
Advances in Experimental Medicine and Biology
|October 30, 2020
Summary
Tumor plasticity enables cancer cells to evade treatments and spread. Targeting the HGF/c-Met pathway in the tumor microenvironment offers a potential strategy to overcome cancer
Area of Science:
- Oncology
- Cancer Biology
- Molecular Signaling
Background:
- Tumor plasticity enhances cancer cell survival, drug resistance, and metastasis.
- Cancer cells adapt to microenvironmental stresses like hypoxia and nutrient deprivation.
- Tumor plasticity is driven by stem-like signaling pathways and tumor microenvironment (TME) interactions.
Purpose of the Study:
- To review the role of the HGF/c-Met signaling pathway in tumor-stroma crosstalk.
- To highlight novel findings on HGF/c-Met's involvement in tumor plasticity.
- To explore its contribution to immune escape and adaptive mechanisms.
Main Methods:
- Literature review focusing on HGF/c-Met signaling.
- Analysis of studies investigating tumor-stroma interactions.
- Synthesis of research on cancer cell plasticity and TME.
Main Results:
- HGF/c-Met signaling is crucial for communication between cancer cells and the TME.
- This pathway supports tumor growth, spread, and the development of resistance.
- It plays a significant role in enabling cancer cells to escape immune surveillance.
Conclusions:
- The HGF/c-Met pathway is a key mediator of tumor plasticity and progression.
- Targeting HGF/c-Met signaling represents a potential therapeutic strategy.
- Understanding this crosstalk is vital for developing effective cancer treatments.
Related Concept Videos
02:38Mitogens and the Cell Cycle
7.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
02:17The Tumor Microenvironment
7.4K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.4K
02:30Metastasis
6.2K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.2K
01:24Regulation of Angiogenesis and Blood Supply
3.1K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.1K
03:03mTOR Signaling and Cancer Progression
4.3K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.3K
01:19Interactions Between Signaling Pathways
7.0K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.0K